Distress Levels in Patients with Premenstrual Dysphoric Disorder
نویسندگان
چکیده
منابع مشابه
Premenstrual Dysphoric Disorder
Around 3-8% of all women in reproductive age suffer from premenstrual dysphoric disorder (PMDD) which disenables them to live an ordinary life during the luteal phase (premenstrual phase) of the menstrual cycle. Throughout the premenstrual phase these women experience emotional, cognitive and physiological changes. Hitherto, the etiology of this disorder is unknown. Some consider the source of ...
متن کاملPremenstrual Dysphoric Disorder
PMDD & Women Casablanca ------------------------------------------------------Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca Authors : McHichi alami Kh, Tahiri SM, Moussaoui D, Kadri N. Centre Psychiatrique Universitaire Ibn Rochd, Casablanca, Maroc.. Summary : Menstruation is a biological phenomenon that has been subject of myths and taboos within and...
متن کاملPremenstrual syndrome and premenstrual dysphoric disorder.
Premenstrual syndrome is defined as recurrent moderate psychological and physical symptoms that occur during the luteal phase of menses and resolve with menstruation. It affects 20 to 32 percent of premenopausal women. Women with premenstrual dysphoric disorder experience affective or somatic symptoms that cause severe dysfunction in social or occupational realms. The disorder affects 3 to 8 pe...
متن کاملTreatment of premenstrual dysphoric disorder.
Premenstrual dysphoric disorder (PMDD) is comprised of a cluster of affective, behavioral and somatic symptoms recurring monthly during the luteal phase of the menstrual cycle. The disorder affects 3-8% of menstruating women and represents the more severe and disabling end of the spectrum of premenstrual disorders, which includes premenstrual syndrome and premenstrual aggravation of underlying ...
متن کاملTreating comorbid premenstrual dysphoric disorder in women with bipolar disorder.
A 34-year-old woman has a diagnosis of bipolar disorder type I (BDI) and is currently euthymic on 7 mg daily of aripiprazole. A comorbid diag nosis of premenstrual dysphoric disorder (PMDD) was confirmed with 2 months of prospective charting. She was initiated on an oral contraceptive (estradiol 30 mcg plus levonorgestrel 0.15 mg daily), and after 6 weeks of treatment she noted substantial impr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Canadian Journal of Psychiatry
سال: 2002
ISSN: 0706-7437,1497-0015
DOI: 10.1177/070674370204700920